Upcoming 2020 Webinars for MDS Patients & Caregivers
Upcoming 2020 Webinars for MDS Patients & Caregivers LIVING with MDS . The diagnosis of MDS is often unexpected and filled with both immediate and long-term challenges. You probably have many questions. Whether you are a newly diagnosed patient, a long-term survivor, or caregiver, our webinar series will have something for you.
Given the growing concerns surrounding COVID-19 and for the safety of our attendees, the MDS Foundation will be hosting a series of webinars in place of our in-person patient forums for the remainder of 2020. We will be collaborating with renowned hematology professionals who will be addressing key topics and questions you may have using language that is easy to understand in a 90-minute format that will include live Q&A opportunities for all participants.
Register now for our 8 webinars planned for this series. Led by top thought leaders in the field, you can be assured you are getting information you can trust.
- June 13, 2020: Treatment of High Risk MDS and the Indication for Stem Cell Transplant @12 pm EDT
Speaker: Prapti Patel, MD; University of Texas Southwestern
This webinar will provide an overview of high-risk MDS, secondary AML, and indication for stem cell transplant, focusing on strategies for patient management. Risk assessment, treatment options, as well as resources for patients and caregivers will be discussed.
- June 27, 2020: Familial MDS @ 12 pm EDT
Speaker: Jane Churpek, MD, MS; UW Carbone Cancer Center, University of Wisconsin School of Medicine
This webinar will provide an overview of familial MDS, focusing on whether MDS is hereditary and can you give MDS to loved ones. Inherited genetic predisposition for developing MDS and congenital abnormalities will be discussed. Click Here to Participate
- July 18, 2020: Low-Risk MDS: Can we prevent progression? Updates from EHA 2020 will also be presented. @12 pm EDT
Speaker: Casey L. O’Connell, MD; University of Southern California, Keck School of Medicine
This webinar will provide an overview summarizing changes in the treatment landscape for patients with low-risk myelodysplastic syndromes. The concerns of low-risk MDS patients and their caregivers will be addressed. Click Here to Participate
- July 25, 2020: What is MDS? How Do We Determine Prognosis? @ 12 pm EDT
Speaker: Jamile Shammo, MD; Rush University Medical Center
This webinar will provide an overview of MDS and how prognosis is determined, focusing on the MDS subtypes and disease process of MDS. Understanding the diagnosis of MDS, details about the various approaches to treatment, and answers to common questions will be discussed. Click Here to Participate
- August 8, 2020: MDS Therapies & Options in 2020 @12 pm EDT
Speaker: James M. Foran, MD, FRCPC; Mayo Clinic Cancer Center, Jacksonville, FL
This webinar will provide an overview of the current treatment strategies for MDS patients. The latest promising clinical trials and research findings impacting the biology and treament of MDS patients will be discussed. Click Here to Participate
- August 29, 2020: Emerging Treatments for Low-Risk MDS @12 pm EDT
Speaker: Barry Skikne, MD, The University of Kansas Cancer Center
This webinar will provide an overview on low-risk MDS focusing on strategies for patient management. Details on the various approaches to treatment including new promising clinical trials and answers to concerns of patients will be discussed. Click Here to Participate
- September 26, 2020: MDS Support Group Webinar @12 pm EDT
Speaker: Jean A. Ridgeway, DNP,APN,NP-C,AOCN
MDS Foundation International Nurse Leadership Board
This webinar will address all aspects of becoming a partner in your care. Whether you are a patient or caregiver, you will be able to connect with others, gather ideas and learn about resources. Click Here to Participate
- October 10, 2020: Stem Cell Transplant for MDS @12 pm EDT
Speaker: Joseph P. McGuirk, D.O.
University of Kansas Medical Center
This webinar will provide an overview of the epidemiology of MDS. Risk Assessment, IPSS-R Prognostic Risk Categories, Allogeneic HCT will be discussed. Click Here to Participate
Learn from experts about treatment therapies and strategies for Patients & Caregiver LIVING with MDS.
Thank you to Acceleron, Bristol-Myers Squibb, Jazz, Novartis, and Takeda for supporting these important events.